The purpose of this study was to determine the expression and cellular functions of the epithelial NADPH oxidase DUOX1 during alveolar type II cell development. When human fetal lung cells (gestational age 11-22 weeks) were cultured to confluency on permeable filters, exposure of cells to a hormone mixture (dexamethasone, 8-bromo-cAMP, isobutyl-methyl xanthine; referred to as DCI) resulted in differentiation of cells into a mature type II phenotype as assessed by expression of lamellar bodies, surfactant proteins, and transepithelial electrical parameters. After 6 days in culture in presence of DCI, transepithelial resistance (2616 ± 529 Ω⋅cm 2 ) and potential (-8.5 ± 0.6 mV) indicated epithelial polarization. At the same time treatment with DCI significantly increased the mRNA expression of DUOX1 (~21-fold), its maturation factor DUOXA1 (~12-fold), as well as DUOX protein (~12-fold), which was localized near the apical cell pole in confluent cultures. For comparison, in fetal lung specimens, DUOX protein was not detectable up to 27 weeks of gestational age but was strongly upregulated after 32 weeks. Function of DUOX1 was assessed by measuring H 2 O 2 and acid production. Rates of H 2 O 2 production were increased by DCI treatment and blocked by small interfering RNA directed against DUOX1 or by diphenylene iodonium.
INTRODUCTION
The NADPH oxidase is a prominent mechanism of innate defense best described in professional phagocytes where NADPH oxidase-derived superoxide (O 2
•-) in the phagosome is critically important for bacterial killing (42) . A number of isoforms of the phagocytic NADPH oxidase have been identified in non-myeloid cell types resulting in the recognition of the NOX gene family consisting of five small (NOX1 to NOX5) and two large members (DUOX1, DUOX2). All of these genes encode membrane proteins that share the structural characteristics of intracellular NADPH and FAD bindings sites and two membrane-embedded hemes that support electron transfer from intracellular NADPH to extracellular oxygen (5) . NADPH oxidase activity further results in the production of intracellular H + (from NADPH, ref. (14)).
Two DUOX isoforms were initially identified and cloned from the thyroid (12, 15) where DUOX is expressed in the apical membrane and provides follicular H 2 O 2 for the oxidation of iodide to iodine during the synthesis of thyroid hormone (11). Apart from the thyroid, DUOX has been mainly found in epithelial tissues that are continuously exposed to microbes, where DUOX is considered to function as a component of the innate defense barrier. DUOX was found to be expressed in rectal mucosa (22) , colon (16) , the entire intestinal tract (17) , salivary glands (22) , airways (20, 22, 40) , and the lung (16) . The DUOX1 and DUOX2
proteins are 77% identical and 83% similar, however, the specific roles for these highly similar proteins are currently unclear. Recently, two ER-associated DUOX maturation factors (DUOXA1 and DUOXA2) were identified which were required for normal translocation of DUOX1 and DUOX2 protein, respectively, to the plasma membrane (24) .
46
). In the current study we sought to identify the NADPH oxidase expressed by human alveolar cells, to determine its developmental and hormonal regulation, and to investigate its cellular function. This was investigated in a cell culture model of human primary fetal epithelial cells that were differentiated into an adult type II cell phenotype by hormone treatment. We found that hormone-differentiated alveolar type II cells showed upregulated DUOX1 in vitro and, similarly, during gestational development shortly before birth in vivo. DUOX1 expression resulted in release of H 2 O 2 and acid into the mucosal medium of differentiated cultures. We propose that the developmental upregulation of DUOX1 before birth prepares the lung host defenses for extra-uterine exposure to pathogens.
MATERIALS AND METHODS

Cell culture. Human fetal lung tissues of 11-22 week gestation abortuses were obtained from Advanced
Bioscience Resources (Alameda, CA) and/or the Birth Defects Laboratory of the University of Washington (Seattle, WA). Lung epithelial cells of approximately 88% purity (47) were isolated and cultured as previously described (23) under approved IRB protocols. Briefly, the tissue was digested with trypsin, collagenase and DNase, fibroblasts were removed by differential adherence, and non-adherent cells were plated on transparent permeable filters (Costar 12 mm Snapwell, 0.4 µm pore size, Corning) at a density of ~0.5 to 0.75 x 10 6 cells per filter in Waymouth's medium supplemented with 10% fetal calf serum. After overnight culture (day 1), attached cells were cultured an additional 3 to 9 days in serum-free Waymouth's medium alone (control) or with addition of DCI (10 nM dexamethasone, 0.1 mM 8-Br-cAMP, 0.1 mM isobutyl methylxanthine) to induce type II cell differentiation (23). Transepithelial resistance (R t ) and voltage (V t ) were measured daily under sterile conditions using a two-electrode volt-ohm meter (EVOM, World Precision Instruments) as described (26); V t is reported as referenced to the serosal side.
Determination of the developmental expression of DUOX was done on banked tissue samples of pre-and postnatal lungs that were obtained through Advanced Bioscience Resources, the Birth Defects Laboratory of the University of Washington, and the Department of Pathology (Children's Hospital of Philadelphia).
Staining for differentiation markers. Alveolar cultures grown on permeable support in absence or presence of DCI were used. Differentiation of cells was assessed using the lipid stain Nile Red (0.1 mg/l) and antibodies against surfactant proteins B (SP-B) and C (SP-C). For immunocytochemistry, cells were fixed with cold methanol and immunostained with antibodies for SP-B (rabbit anti-bovine SP-B, 1:100, Chemicon) and SP-C (Byk-Gulden rabbit anti-rSP-C antibody) as described (37). Prism cycler using Sybr green or Taqman reporters designed to detect human DUOX1, DUOX2, and DUOXA1. Oligonucleotide primers for DUOX1, DUOX2, and GAPDH were as described (40) , primers for DUOXA1 were, forward, 5'-tgggtggagtcaacatcacact-3' and, reverse, 5'-cgttgtaattgatggtctcattcag-3'. mRNA detection was performed in comparison with the GAPDH gene using the difference of PCR cycles to reach a threshold amplification (∆C T ) and by relating treatment groups to controls. Standard curves were generated for both target and endogenous control genes using serial dilutions of cDNA using ABI reagents, 0.4 µM forward and reverse primers, and 50 ng cDNA. To control for specific PCR products, a dissociation curve was generated after the end of the last cycle. Because ratios of mRNA levels of treatment-to-control varied considerably between experiments, averages were calculated from log-transformed ratios.
Immunodetection of DUOX. Total cell extract protein (20 µg protein) was separated by SDS-PAGE.
Proteins were electrophoretically transferred to nitrocellulose membrane, then blocked for 2 h with 5% was low and not affected by DCI treatment ( Fig. 2A , open circles). We also tested whether incubation of cultures with dexamethasone alone or with 8-bromo-cAMP plus isobutylmethylxanthine exerted similar effects and found no significant induction of DUOX1 mRNA (not shown).
RESULTS
Treatment of undifferentiated fetal lung epithelial cultures with DCI results in
In a second set of experiments (6 cultures per group) cultures were treated with DCI (compared to untreated controls) and were investigated for mRNA expression of both DUOX1 and its maturation factor DUOXA1 (24) . DUOXA1 is an ER-resident transmembrane protein necessary for the ER-to-Golgi transition of DUOX1 protein and thus for proper maturation and expression at the plasma membrane (24) . Treatment of cultures with DCI resulted in a closely correlated induction of DUOX1 and DUOXA1 mRNA expression (Fig. 2B&C ).
Protein expression was investigated using an antibody raised against DUOX1 (12). Fig. 3 shows immunoblots and immunocytochemistry from control and DCI-treated cultures. Although the antibody does not distinguish well between DUOX1 and DUOX2 protein (and is thus referred to here as DUOX antibody), the detected protein found in these blots is most likely DUOX1 since the mRNA expression of DUOX2 was unchanged in DCI-treated cultures ( Fig. 2A) Expression and localization of DUOX in alveolar cultures was investigated using confocal microscopy on confluent cultures grown on permeable supports. Cultures were stained for DUOX and in addition for ZO-1 as a marker for the junctional rings and the apical cell pole. In the images shown in Figure 3B , the confocal plane was focused on the ZO-1 signal (red). Cultures treated with DCI for 4 days showed prominent DUOX staining (green). In untreated control monolayers, the DUOX signal was weak, diffuse, and nonspecific.
The expression of DUOX1 mRNA and protein correlated closely over time of DCI treatment (Fig. 3C ).
Isolated undifferentiated human fetal lung epithelial cells were cultured for 3 days in control media, then DCI was added and cells harvested at various times of hormone exposure (4-72 h). DUOX1 mRNA increased by ~4-8 hours of treatment and continuously increased at later times. The increase in DUOX protein content was delayed relative to DUOX1 mRNA but then also increased after 24 to 72 h. The inset in Fig. 3C shows staining intensities of the corresponding immunoblots, with untreated controls (labeled "C")
shown for 8 h and 72 h time points. Figure 3D shows the data from Figure 3C replotted to display the correlation between DUOX protein and mRNA induction during DCI treatment (slope = 0.33 ± 0.05, r 2 = 0.89, p = 0.001).
DUOX expression in fetal lung tissue is developmentally regulated and increases before birth.
For comparison and as a control for the upregulation of DUOX1 in in vitro cell cultures, the developmental expression of DUOX was investigated in human peripheral lung tissue specimens of 15 to 32 weeks of gestational age and in adult tissues using immunoblotting (Fig. 4) . No DUOX-specific bands were detected in 15 to 27-week gestation fetal lungs. Substantial signals were found in a 32-week gestational age specimen and in two adult specimens (Fig. 4) . No other specimen of gestational age older than 32 weeks became available during the course of this study which limited us in further investigating this time window.
Nevertheless, these data indicate a developmental upregulation of DUOX in lung tissue during the late gestational period that is then maintained in adult lung. This was assessed in fetal lung epithelial cultures using three functional outcome measures of NADPH oxidase activity: 1) release of H 2 O 2 into the medium, 2) intracellular acid production, and 3) mucosal acid secretion. The role of DUOX1 in NADPH oxidase function was tested using DUOX1-specific siRNA. First, the efficiency of three different siRNA oligonucleotides directed against DUOX1 was determined using real-time PCR (Fig. 5A) . siRNA was electroporated into cells and then cells were cultured in presence of DCI for 3 days. Each of the siRNA's significantly reduced the expression of DUOX1 mRNA when compared to a scrambled oligonucleotide of the 2598 siRNA sequence. 2725 siRNA was particularly effective and was further utilized for functional studies. For comparison, and to test for any effects of the scrambled siRNA, cells were also treated using the identical electroporation and culture procedure but without siRNA (mock), which resulted in DUOX1 expression similar to the treatment with scrambled siRNA. Figure 6A shows pH i recordings from control and DCItreated cells and Figure 6B shows average steady-state pH i values before and after treatment with blockers.
Initial pH i was similar in DCI-treated and untreated cells (on average, pH i = 7.31 ± 0.28). Addition of 1 mM amiloride (to block the Na + /H + -exchanger) and the subsequent addition of 100 µM ZnCl 2 (to block H + channels) significantly acidified DCI-treated cells but showed no effects in control cells (Fig. 6A&B) 
DCI-treated cultures show increased acid secretion.
Release of H + into the mucosal compartment was investigated using the pH stat titration technique in Ussing chambers. Figure 7A shows original recordings of titrations of the mucosal pH to ~7.3 of untreated (top) and DCI-treated (bottom) cultures by repeated additions of NaOH (at arrows) to determine the rates of H + secretion (J H ) by the epithelium. Average J H was significantly increased in DCI-treated cultures compared to control (Fig. 7B ). When 0.5 mM amiloride was added to the serosal side of DCI-treated cultures, acid secretion was further increased suggesting that intracellularly generated H + was redirected to the mucosal side (Fig. 7C) . Addition of 100 µM ZnCl 2 to the mucosal side blocked a substantial fraction of H + secretion (Fig. 7C) . These experiments indicate that DCItreated alveolar cultures release intracellular acid by way of a basolateral Na + /H + exchanger and apical H + channels. In contrast, untreated control cells showed little acid production and release. These data are consistent with the notion that upregulated DUOX1 expression in DCI-treated cultures results in increased intracellular acid production ( Fig. 6 ) and secretion (Fig. 7B ).
DISCUSSION
Expression of DUOX1 in alveolar cells. In this study we investigated the expression and function of the NADPH oxidase isoform DUOX1 in the alveolar epithelium. Using a hormonally induced primary epithelial cell culture model of human alveolar epithelium, we found increased DUOX1 expression, H 2 O 2 release, and acid production in vitro during differentiation of precursor cells to epithelial alveolar type II cells, and in vivo the expression of DUOX was upregulated at gestational age of 32 weeks.
DUOX1 and DUOX2 are highly similar proteins (83% sequence similarities, ref. (12)). We focused our study on DUOX1 based on the previous observation in a microarray study that DUOX1 mRNA expression was increased during alveolar type II cell differentiation (47) . This observation was further confirmed in the current study using quantitative PCR ( Fig. 2A) . In contrast the expression of DUOX2 mRNA appeared lower ( Fig. 2A) , was previously not detected by microarray (47), and was not increased during in vitro differentiation ( Fig. 2A) . Consistent with these data, in a recent quantitative PCR study on rat lung maturation, DUOX2 mRNA was found to be slightly down-regulated between gestational day 18 and adult rat lung (49) . In addition, we found that mRNA levels of the maturation factor DUOXA1 closely followed DUOX1 mRNA (Fig. 2C ) consistent with an increased production of membrane-localized, functional DUOX1 protein in differentiated cells in vitro. Similarly, in a previous tissue expression profiling study, DUOXA1 was highly expressed in lung tissue while the corresponding maturation factor DUOXA2 was not detected (24) . These reports support our observation that DUOX1 is the dominant DUOX isoform in differentiated adult lung epithelia.
The mode of regulation of DUOX1 gene expression is not known. DUOX1 is located on chromosome 15 in a complex locus containing both DUOX1 and its maturation factor DUOXA1 (12, 24, 35), which are arranged head to head and might share a bidirectional promoter (24) . Recent genome-wide analyses indicate that bidirectionally promoted gene pairs represent ~9% of all transcriptional units and have a higher probability of coordinated expression than random pairs of genes (18, 43, 44) . In support of this notion, we found a close correlation between the level of induction for DUOX1 and DUOXA1 expression in our study when cells were stimulated with DCI (Fig. 2C) .
In our study 8-Br-cAMP alone had no effect on the expression of DUOX1 in lung cells, however, DUOX1
and DUOX2 mRNA levels in Northern blots of dog thyroid (12) or DUOX2 in porcine thyroid follicles (29) were found to be upregulated when cultured in forskolin for 2-3 days, while the effects in human thyroid were small (12). In a later investigation of the promoter regions of the DUOX isoforms, a cAMP regulation of the human promoters was not found (35). Combined treatment with cAMP, IBMX and dexamethasone strongly upregulated DUOX1 (but not DUOX2) expression in our study ( and maintain a relatively reduced alveolar environment. GPx1 and catalase mRNA expression were found to be upregulated in adult compared to fetal human lung tissue (2) , and in a recent microarray study we found that GPx3 mRNA expression was increased 3.7-fold by DCI treatment of human fetal alveolar cultures (47) . The upregulation of both oxidant production (DUOX1) and antioxidant mechanisms during type II cell differentiation suggests that these two systems interact to maintain a controlled redox equilibrium.
DUOX1-mediated acid production and secretion by alveolar cells. The alveolar lining fluid in rabbit lungs
has been described as slightly acidic (pH = 6.9) and epithelial H + secretion has been suggested (33 indicating a role for DUOX1 in intracellular acidification. The simplest explanation of these data is that DUOX1 expression in differentiated alveolar cells generates intracellular H + during NADPH oxidation, similar to the activity of NADPH oxidases in phagocytes (14) or airway epithelia (40) . Whether there are other sources of intracellular acid that are upregulated in parallel to or by DUOX1 is currently not known.
Although secretion of H + by the alveolar epithelium has been suggested to contribute to the acidic mucosal pH, H + secretion into the mucosal bath has not been formally measured. We found that DCI-treated cells continuously acidified the mucosal bath, which appeared largely H + channel-mediated. This is noteworthy because previously H + channels have been found to be inactive under basal conditions (32) and only activated after an acidic challenge. Note, however, that the transepithelial experiments (Fig. 6 ) were performed at a relatively alkaline mucosal pH of 7.3, which is expected to increase the inside-to-outside gradient for H + and amplify the measured H + secretion. Taken together these data are consistent with the notion that the alveolar mucosa acidifies by DUOX1-associated intracellular H + production, which generates a H + gradient to drive H + secretion.
Possible role of DUOX1 in pulmonary innate host defense. DUOX1 is a member of the NOX gene family of NADPH oxidases. The first and most intensely investigated member of the NOX family is gp91 phox (now called NOX2) of phagocytic cells, which is unequivocally involved in innate defense (42) . DUOX1 and DUOX2 appear to be the epithelial NADPH oxidase isoforms and there are a number of observations in airways that support a role in innate mucosal defense (20, 22, 31) . Further supporting evidence comes from a study on isolated adult rat alveolar type II cells that showed that H 2 O 2 release was substantially increased when type II cells were exposed to S. aureus or the yeast cell wall particle zymosan (46). HOSCN (22, 51) . In contrast to the peroxidases found in other tissues, the presence of a complementary peroxidase in alveolar cells is unclear.
The only well-described peroxidase present in the alveolar lining fluid is GPx (3), which is a seleniumcontaining peroxidase that is structurally unrelated to the above mentioned peroxidases. In presence of the high concentrations of glutathione in the alveolar lining fluid (6) Faint non-specific bands were present in all samples. 
